Single rapid real-time monitored isothermal RNA amplification assay for quantification of human immunodeficiency virus type 1 isolates from groups M, N, and O

被引:56
作者
de Baar, MP
van Dooren, MW
de Rooij, E
Bakker, M
van Gemen, B
Goudsmit, J
de Ronde, A
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Human Retrovirol, NL-1105 AZ Amsterdam, Netherlands
[2] PrimaGen, Amsterdam, Netherlands
[3] Amsterdam Inst Viral Genomics, Amsterdam, Netherlands
关键词
D O I
10.1128/JCM.39.4.1378-1384.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Because human immunodeficiency virus type 1 (HIV-1) subtypes and circulating recombinant forms (CRFs) are spreading rapidly worldwide and are becoming less confined to a geographical area, RNA assays that can detect and quantify all HIV-1 isolates reliably are in demand. We have developed a fast, real-time monitored RNA assay based on an isothermal nucleic acid sequence-based amplification technology that amplifies a part of the long terminal repeat region of the HIV-1 genome. Real-time detection was possible due to the addition of molecular beacons to the amplification reaction that was monitored in a fluorimeter with a thermostat. The lower le c el of detection of the assay was 10 HIV-1 RNA molecules per reaction, and the lower level of quantification was 100 copies of HIV-1 RNA,vith a dynamic range of linear quantification between 10(2) and 10(7) RNA molecules. All HIV-1 groups, subtypes, and CRFs could be detected and quantified with equal efficiency, including the group N isolate YBF30 and the group O isolate ANT70, To test the clinical utility of the assay, a series of 62 serum samples containing viruses that encompassed subtypes A through G and CRFs AE and AG of HIV-1 group M were analyzed, and these results were compared to the results of a commercially available assay. This comparison showed that the quantification results correlated highly (R-2 = 0.735) for those subtypes that could be well quantified by both assays (subtypes B, C, D, and Fl, whereas improved quantification was obtained for subtypes A and G and CRFs AE and Ac, A retrospective study with six individuals infected with either a subtype A, B, C, or D or an AG isolate of HIV-1 group hi, who were treated with highly active antiretroviral therapy, revealed that the assay was well suited to the monitoring of therapy effects.. In conclusion, the newly developed real-time monitored HIV-I assay is a fast and sensitive assay with a large dynamic range of quantification and is suitable for quantification of most if not all subtypes and groups of HIV-1.
引用
收藏
页码:1378 / 1384
页数:7
相关论文
共 35 条
[1]   Subtype-specific problems with quantification of plasma HIV-1 RNA [J].
Alaeus, A ;
Lidman, K ;
Sonnerborg, A ;
Albert, J .
AIDS, 1997, 11 (07) :859-865
[2]   RAPID AND SIMPLE METHOD FOR PURIFICATION OF NUCLEIC-ACIDS [J].
BOOM, R ;
SOL, CJA ;
SALIMANS, MMM ;
JANSEN, CL ;
WERTHEIMVANDILLEN, PME ;
VANDERNOORDAA, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (03) :495-503
[3]  
Coste J, 1996, J MED VIROL, V50, P293, DOI 10.1002/(SICI)1096-9071(199612)50:4&lt
[4]  
293::AID-JMV3&gt
[5]  
3.0.CO
[6]  
2-3
[7]   Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo [J].
de Baar, MP ;
Janssens, W ;
de Ronde, A ;
Fransen, K ;
Colebunders, R ;
Kestens, L ;
van der Groen, G ;
Goudsmit, J .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (14) :1385-1394
[8]   Design and evaluation of a human immunodeficiency virus type 1 RNA assay using nucleic acid sequence-based amplification technology able to quantify both group M and O viruses by using the long terminal repeat as target [J].
De Baar, MP ;
van der Schoot, AM ;
Goudsmit, J ;
Jacobs, F ;
Ehren, R ;
van der Horn, KHM ;
Oudshoorn, P ;
De Wolf, F ;
De Ronde, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (06) :1813-1818
[9]  
De Baar MP, 2000, AIDS RES HUM RETROV, V16, P499
[10]   AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: Markers with reciprocal predictive value over time after seroconversion [J].
deWolf, F ;
Spijkerman, I ;
Schellekens, PT ;
Langendam, M ;
Kuiken, C ;
Bakker, M ;
Roos, M ;
Coutinho, R ;
Miedema, F ;
Goudsmit, J .
AIDS, 1997, 11 (15) :1799-1806